Joseph Baar

1.6k total citations
32 papers, 1.2k citations indexed

About

Joseph Baar is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Joseph Baar has authored 32 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 13 papers in Oncology and 13 papers in Immunology. Recurrent topics in Joseph Baar's work include Immunotherapy and Immune Responses (12 papers), RNA Interference and Gene Delivery (7 papers) and Cancer Immunotherapy and Biomarkers (5 papers). Joseph Baar is often cited by papers focused on Immunotherapy and Immune Responses (12 papers), RNA Interference and Gene Delivery (7 papers) and Cancer Immunotherapy and Biomarkers (5 papers). Joseph Baar collaborates with scholars based in United States, Canada and India. Joseph Baar's co-authors include Thomas Tüting, Walter J. Storkus, Steven A. Burton, Cihat Ozhasoglu, Peter C. Gerszten, William C. Welch, William J. Vogel, Cara C. Wilson, Yvette L. Kasamon and Craig L. Slingluff and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Immunology and Cancer.

In The Last Decade

Joseph Baar

32 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Joseph Baar United States 16 539 423 362 272 215 32 1.2k
Jeffrey M. Venstrom United States 21 949 1.8× 643 1.5× 248 0.7× 240 0.9× 224 1.0× 99 1.9k
Hiroshi Nakagomi Japan 16 435 0.8× 558 1.3× 272 0.8× 162 0.6× 194 0.9× 58 1.2k
Anne Bastian United States 10 552 1.0× 509 1.2× 265 0.7× 211 0.8× 135 0.6× 12 895
Pia Klausen Denmark 16 291 0.5× 387 0.9× 246 0.7× 118 0.4× 105 0.5× 33 928
Floyd A. Benko United States 10 417 0.8× 404 1.0× 561 1.5× 117 0.4× 232 1.1× 12 1.2k
An Coosemans Belgium 21 545 1.0× 523 1.2× 409 1.1× 283 1.0× 80 0.4× 76 1.6k
Dominic Fong Austria 21 241 0.4× 916 2.2× 645 1.8× 239 0.9× 134 0.6× 33 1.7k
Isabelle Veys Belgium 19 339 0.6× 908 2.1× 278 0.8× 228 0.8× 186 0.9× 67 1.5k
Michael Andreeff United States 10 166 0.3× 330 0.8× 336 0.9× 160 0.6× 258 1.2× 19 1.0k
Takaaki Hato Japan 17 242 0.4× 210 0.5× 322 0.9× 92 0.3× 126 0.6× 83 1.2k

Countries citing papers authored by Joseph Baar

Since Specialization
Citations

This map shows the geographic impact of Joseph Baar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joseph Baar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joseph Baar more than expected).

Fields of papers citing papers by Joseph Baar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joseph Baar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joseph Baar. The network helps show where Joseph Baar may publish in the future.

Co-authorship network of co-authors of Joseph Baar

This figure shows the co-authorship network connecting the top 25 collaborators of Joseph Baar. A scholar is included among the top collaborators of Joseph Baar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joseph Baar. Joseph Baar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Stabellini, Nickolas, Paul G. Pavicic, Pingfu Fu, et al.. (2023). Phase II Clinical Trial of Pembrolizumab and Chemotherapy Reveals Distinct Transcriptomic Profiles by Radiologic Response in Metastatic Triple-Negative Breast Cancer. Clinical Cancer Research. 30(1). 82–93. 8 indexed citations
2.
Peereboom, D., Conleth G. Murphy, Manmeet S. Ahluwalia, et al.. (2014). Phase II trial of patupilone in patients with brain metastases from breast cancer. Neuro-Oncology. 16(4). 579–583. 22 indexed citations
3.
Siroy, Alan, Fadi W. Abdul‐Karim, John D. Miedler, et al.. (2013). MUC1 is expressed at high frequency in early-stage basal-like triple-negative breast cancer. Human Pathology. 44(10). 2159–2166. 72 indexed citations
4.
Cai, Quan-Ying, et al.. (2009). Optimized Systemic Dosing with CpG DNA Enhances Dendritic Cell‐Mediated Rejection of a Poorly Immunogenic Mammary Tumor in BALB/c Mice. Clinical and Translational Science. 2(1). 62–66. 4 indexed citations
5.
Baar, Joseph. (2007). Biological therapy of breast cancer: recent clinical applications.. PubMed. 8(12). 987–95. 1 indexed citations
6.
Margolin, Kim, Michael B. Atkins, Janice P. Dutcher, et al.. (2007). Phase I Trial of BAY 50-4798, an Interleukin-2–Specific Agonist in Advanced Melanoma and Renal Cancer. Clinical Cancer Research. 13(11). 3312–3319. 43 indexed citations
7.
Gerszten, Peter C., Steven A. Burton, Cihat Ozhasoglu, et al.. (2005). Stereotactic radiosurgery for spinal metastases from renal cell carcinoma. Journal of Neurosurgery Spine. 3(4). 288–295. 169 indexed citations
8.
Kondziolka, Douglas, Juan J. Martin, John C. Flíckinger, et al.. (2005). Long‐term survivors after gamma knife radiosurgery for brain metastases. Cancer. 104(12). 2784–2791. 101 indexed citations
9.
Day, Roger, Adam Brufsky, Joseph Baar, et al.. (2004). Evaluation of the OncoTCap(Oncology Thinking Cap) Simulation in Teaching Medical Students About Clinical Trials: Some Successes and Some Surprises. Journal of Cancer Education. 19(3). 149–155. 1 indexed citations
10.
Shimamura, Hiromune, et al.. (2002). Murine Dendritic Cell-Induced Tumor Apoptosis is Partially Mediated by Nitric Oxide. Journal of Immunotherapy. 25(3). 226–234. 25 indexed citations
11.
Hmelo, Cindy E., Sailesh Ramakrishnan, Roger Day, et al.. (2001). Oncology Thinking Cap: Scaffolded Use of a Simulation to Learn Clinical Trial Design. Teaching and Learning in Medicine. 13(3). 183–191. 10 indexed citations
12.
Baar, Joseph. (1999). Clinical Applications of Dendritic Cell Cancer Vaccines. The Oncologist. 4(2). 140–144. 14 indexed citations
13.
Tüting, Thomas, Cara C. Wilson, Joseph Baar, et al.. (1998). DNA Vaccines Targeting Dendritic Cells for the Immunotherapy of Cancer. Advances in experimental medicine and biology. 451. 295–304. 7 indexed citations
14.
Lui, Vivian Wai Yan, Joseph Baar, Ling Wang, et al.. (1998). Potentiation of E7 antisense RNA-induced antitumor immunity by co-delivery of IL-12 gene in HPV16 DNA-positive mouse tumor. Gene Therapy. 5(11). 1462–1471. 9 indexed citations
15.
16.
17.
Baar, Joseph, et al.. (1996). Analysis of a hot spot for DNA insertion suggests a mechanism for Ig switch recombination. The Journal of Immunology. 157(8). 3430–3435. 11 indexed citations
18.
Baar, Joseph & Marc J. Shulman. (1995). The Ig heavy chain switch region is a hotspot for insertion of transfected DNA. The Journal of Immunology. 155(4). 1911–1920. 15 indexed citations
19.
Baar, Joseph, Ronald L. Burkes, Robert S. Bell, et al.. (1994). Primary non-Hodgkin's lymphoma of bone. A clinicopathologic study. Cancer. 73(4). 1194–1199. 89 indexed citations
20.
Baar, Joseph & Ian F. Tannock. (1989). Analyzing the same data in two ways: a demonstration model to illustrate the reporting and misreporting of clinical trials.. Journal of Clinical Oncology. 7(7). 969–978. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jeffrey M. Venstrom Breakdown of academic impact, for papers by Hiroshi Nakagomi Breakdown of academic impact, for papers by Anne Bastian Breakdown of academic impact, for papers by Pia Klausen Breakdown of academic impact, for papers by Floyd A. Benko Breakdown of academic impact, for papers by An Coosemans Breakdown of academic impact, for papers by Dominic Fong Breakdown of academic impact, for papers by Isabelle Veys Breakdown of academic impact, for papers by Michael Andreeff Breakdown of academic impact, for papers by Takaaki Hato
Rankless by CCL
2026